APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
NCT04657861
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma in Relapse
Multiple Myeloma, Refractory
Interventions
DRUG:
APRIL CAR-T cells
Sponsor
Zhejiang University
Collaborators
[object Object]